openPR Logo
Press release

PEGylated Protein Therapeutics Market Analysis Focusing on Top Key Players – Amgen Inc., AstraZeneca PLC, Biogen, Inc., F. Hoffmann-La Roche Ltd. and more

12-11-2018 10:00 AM CET | Health & Medicine

Press release from: Allied Market Research

PEGylated Protein Therapeutics Market

PEGylated Protein Therapeutics Market

PEGylated Protein Therapeutics Market is growing at a CAGR of 6.9%, anticipated to reach $17,813 million by 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

The factors that drive the growth of the global PEGylated protein therapeutics market are increase in prevalence of chronic diseases, advantages offered by PEGylation, and strong presence of pipe line drugs are. However, high cost related to drug development and launch of generics during the forecast period are expected to impede the market growth. In addition, high market potential in the untapped emerging economies and increase in adoption of PEGylated protein therapeutics are expected to provide many opportunities during the forecast period.

By product type, the colony stimulating factor segment accounted for nearly half share of the global occupational medicine market in 2017. Furthermore, the cancer segment is anticipated to grow at the highest rate of 7.4% during the forecast period.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/3726?utm_source=sy-Openpr

The report provides an extensive competitive analysis and profiles of the key market players such as
• Amgen Inc.
• AstraZeneca PLC
• Biogen Inc.
• F. Hoffmann-La Roche Ltd. (Genentech Inc.)
• Horizon Pharma plc.
• Leadiant Biosciences S.p.A.
• Merck & Co.
• Inc. (Schering-Plough Corporation)
• Pfizer Inc.
• Shire plc (Baxalta)
• UCB S.A.

PEGylation is a process of addition of active polyethylene glycol (PEG) to different forms of therapeutic proteins for chemical modification. These chemically modified therapeutic proteins are called PEGylated protein therapeutics. The chemical modification due to PEGylation results in various advantages, such as an extended half-life of a drug along with low toxicity and increased proteolytic protection, over the non-modified protein therapeutics. PEGylated protein therapeutics are used in multiple conditions such as cancer, hemophilia, rheumatoid arthritis, ankylosing spondylitis, Crohns disease, and others.

Buy Now (Data Pack Available with Discounted Price): @ https://www.alliedmarketresearch.com/checkout/729671?utm_source=sy-Openpr

Key Findings of the PEGylated Protein Therapeutics Market:
• North America occupied nearly two-thirds share of the global PEGylated protein therapeutics market in 2017
• The cancer segment is anticipated to grow with the highest CAGR throughout the forecast period.
• Europe is anticipated to occupy one-fifth market share of the global PEGylated protein therapeutics market by 2025.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

North America was the leading revenue contributor to the global market in 2017, owing to FDA approval and launch of new drugs in this region. However, Asia-Pacific is expected to grow at the highest CAGR of 7.4% from 2018 to 2025, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward chronic disorders.

Access Full Summery @ https://www.alliedmarketresearch.com/PEGylated-proteins-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PEGylated Protein Therapeutics Market Analysis Focusing on Top Key Players – Amgen Inc., AstraZeneca PLC, Biogen, Inc., F. Hoffmann-La Roche Ltd. and more here

News-ID: 1431328 • Views:

More Releases from Allied Market Research

Philippines Beauty & Personal Care Market Size is Projected to Surpass US$ 4.7 billion Through 2026 | Allied Market Research
Philippines Beauty & Personal Care Market Size is Projected to Surpass US$ 4.7 b …
The Philippines beauty & personal care market size was valued at $3.3 billion in 2018 and is projected to reach $4.7 billion by 2026, registering a CAGR of 4.8% from 2019 to 2026.The Hypermarket/Supermarket segment was the highest contributor to the market, with $801.5 million in 2018. Request The Sample PDF of This Report: https://www.alliedmarketresearch.com/request-sample/6493 Market Overview Beauty & personal care products are the products that are used for
Yoga Clothing Market to Surge USD 70,291.0 million by 2030, Size, Share, Emerging Trends, Key Growth Drivers
Yoga Clothing Market to Surge USD 70,291.0 million by 2030, Size, Share, Emergin …
The global yoga clothing market size is expected to reach $70,291.0 million by 2030 at a CAGR of 7.8% from 2021 to 2030. Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/14563 Yoga is a combination of spiritual, physical, and mental discipline originated in India. It is a holistic discipline based on an extremely subtle science, majorly focusing on bringing harmony between body and mind. Yoga is well-known for promotion
Smart Railway Market to Surge at CAGR of 12.8% -2027 | Huawei Technologies Co., Ltd., BOMBARDIER INC
Smart Railway Market to Surge at CAGR of 12.8% -2027 | Huawei Technologies Co., …
𝐒𝐦𝐚𝐫𝐭 𝐑𝐚𝐢𝐥𝐰𝐚𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 by System (Passenger Information System, Rail & Freight Operations Management System, Smart Safety & Security Monitoring System, Rail communication & Networking System, Smart Ticketing System, Rail Analytics System, and Others) and Offering Type (Solutions, Components & Devices, and Services): Global Opportunity Analysis and Industry Forecast, 2020-2027" According to the report published by Allied Market Research, The global smart railway market size was valued at $18,304.8 million in
Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factors behind Market's Exponential Growth
Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factor …
Allied Market Research published a new report, titled, " The Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factors behind Market's Exponential Growth." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding

All 5 Releases


More Releases for PEG

Biopharma PEG Provides Monodisperse PEGs In Drug Development
Monodisperse PEG products usually are organic compounds with a molecular weight of less than 1000. Monodispersed PEG linkers are pure compounds with a single molecular weight. Monodisperse polyethylene glycol(PEG) molecular weight is fixed. It can not be obtained by polymerization. It must be by the appropriate reaction of the basic polyethylene glycol fragment. With advancements in both synthetic and purification chemistry over the past two decades, monodispersed PEG linkers have become more commercially
High Quality PEG Raw Materials From Biopharma PEG
Polyethylene glycol (PEG) is a polyether compound derived from petroleum with many applications, from industrial manufacturing to medicine. PEG is also known as polyethylene oxide (PEO) or polyoxyethylene (POE), it has wide variety of applications depending on the length of the polymer chain and the molecular weight of the final polymer. The synthesis of PEG is done by polymerizing ethylene oxide, the main ingredient in antifreeze, using a ring-opening
Polyethylene Glycol (PEG) in Medical Market 2021 | Detailed Report
ReportsnReports publishes the report titled Polyethylene Glycol (PEG) in Medical that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital
PEG-3 Distearate Market global outlook and forecast 2021 -2027
The Global PEG-3 Distearate Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a PEG-3 Distearate makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements. The report likewise spins around
The Advantages of Monodisperse PEG In Drug Development?
Monodisperse PEG products usually are organic compounds with a molecular weight of less than 1000. Monodispersed PEG linkers are pure compounds with a single molecular weight. In contrast, polydisperse PEGs linkers contain variations in molecular weight with an average molecular weight. The use of polydisperse PEGs linkers in drug development has led to problems in biological applications due to steric hindrance and binding. With advancements in both synthetic and purification chemistry over the
Application of PEG In Click Chemistry
Polyethylene glycol (PEG) is a biocompatible, synthetic, hydrophilic polyether compound that has many applications, mostly in the medical industry, but also in the chemical and industrial sectors. The synthesis of PEG is done by polymerizing ethylene oxide, the main ingredient in antifreeze, using a ring-opening technique, which allows for PEGs of a range of molecular weights and molecular weight distributions to be constructed. This range in weights is what makes